StoneRidge PMG Advisors, LLC’s AbbVie ABBV Stock Holding History

StoneRidge PMG Advisors, LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.03M	Buy	+3,933	New	+$1.01M	0.72%	27

Other funds holding ABBV

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

StoneRidge PMG Advisors, LLC's ABBV Position: Q3 2026 in Review

StoneRidge PMG Advisors, LLC opened a new position in AbbVie (ABBV) in Q3 2026: 3,933 shares worth $1.03M. The stake represents 0.72% of the portfolio and ranks #27 among its holdings.

2,437 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

StoneRidge PMG Advisors, LLC held 3,933 shares of AbbVie worth $1.03M as of Q3 2026.
AbbVie was a new StoneRidge PMG Advisors, LLC position in Q3 2026.
AbbVie made up 0.72% of StoneRidge PMG Advisors, LLC's portfolio in Q3 2026, its #27 holding.
2,437 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on StoneRidge PMG Advisors, LLC's 13F filing for Q3 2026, filed 4 Nov 2026.